These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30406383)

  • 1. Diagnosis and Treatment of Mitochondrial Myopathies.
    Ahmed ST; Craven L; Russell OM; Turnbull DM; Vincent AE
    Neurotherapeutics; 2018 Oct; 15(4):943-953. PubMed ID: 30406383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of mitochondrial myopathies.
    Milone M; Wong LJ
    Mol Genet Metab; 2013; 110(1-2):35-41. PubMed ID: 23911206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.
    De Paepe B; Smet J; Lammens M; Seneca S; Martin JJ; De Bleecker J; De Meirleir L; Lissens W; Van Coster R
    J Clin Pathol; 2009 Feb; 62(2):172-6. PubMed ID: 19181635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mitochondrial myopathies in childhood.
    Olimpio C; Tiet MY; Horvath R
    Neuromuscul Disord; 2021 Oct; 31(10):978-987. PubMed ID: 34736635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions.
    Taivassalo T; Gardner JL; Taylor RW; Schaefer AM; Newman J; Barron MJ; Haller RG; Turnbull DM
    Brain; 2006 Dec; 129(Pt 12):3391-401. PubMed ID: 17085458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial myopathies in adults and children: management and therapy development.
    Pitceathly RD; McFarland R
    Curr Opin Neurol; 2014 Oct; 27(5):576-82. PubMed ID: 25188013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
    Fosslien E
    Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should a rheumatologist suspect a mitochondrial myopathy?
    Albert DA; Cohen JA; Burns CM; Hickey WF; Prock TL; James JA; Rhodes CH; Wortmann RL
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1497-502. PubMed ID: 22034111
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial DNA deletions in muscle satellite cells: implications for therapies.
    Spendiff S; Reza M; Murphy JL; Gorman G; Blakely EL; Taylor RW; Horvath R; Campbell G; Newman J; Lochmüller H; Turnbull DM
    Hum Mol Genet; 2013 Dec; 22(23):4739-47. PubMed ID: 23847047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of mitochondrial myopathies.
    Pfeffer G; Chinnery PF
    Ann Med; 2013 Feb; 45(1):4-16. PubMed ID: 21867371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
    ; Abouhajar A; Alcock L; Bigirumurame T; Bradley P; Brown L; Campbell I; Del Din S; Faitg J; Falkous G; Gorman GS; Lakey R; McFarland R; Newman J; Rochester L; Ryan V; Smith H; Steel A; Stefanetti RJ; Su H; Taylor RW; Thomas NJP; Tuppen H; Vincent AE; Warren C; Watson G
    Trials; 2022 Sep; 23(1):789. PubMed ID: 36127727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy.
    Gartz M; Haberman M; Sutton J; Slick RA; Luttrell SM; Mack DL; Lawlor MW
    Exp Cell Res; 2023 Mar; 424(2):113507. PubMed ID: 36796746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and training in mitochondrial myopathies.
    Taivassalo T; Haller RG
    Med Sci Sports Exerc; 2005 Dec; 37(12):2094-101. PubMed ID: 16331135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases.
    Rahman S; Hanna MG
    J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):943-53. PubMed ID: 19684231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for treatment of mitochondrial myopathies.
    Taylor RW; Wardell TM; Lightowlers RN; Turnbull DM
    Neurol Sci; 2000; 21(5 Suppl):S909-12. PubMed ID: 11382188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, pathogenic dinucleotide deletion in the mitochondrial MT-TY gene causing myasthenia-like features.
    Lim AZ; McMacken G; Rastelli F; Oláhová M; Baty K; Hopton S; Falkous G; Töpf A; Lochmüller H; Marini-Bettolo C; McFarland R; Taylor RW
    Neuromuscul Disord; 2020 Aug; 30(8):661-668. PubMed ID: 32684384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of mitochondrial myopathies: recent advances.
    DiMauro S
    Acta Myol; 2010 Oct; 29(2):333-8. PubMed ID: 21314015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial myopathy diagnosis.
    Shoffner JM
    Neurol Clin; 2000 Feb; 18(1):105-23. PubMed ID: 10658170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial cytopathy in adults: what we know so far.
    Cohen BH; Gold DR
    Cleve Clin J Med; 2001 Jul; 68(7):625-6, 629-42. PubMed ID: 11453081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the effect of oxidative phosphorylation deficiencies on the skeletal muscle bioenergetic system in patients with mitochondrial myopathies.
    Korzeniewski B
    J Appl Physiol (1985); 2021 Aug; 131(2):768-777. PubMed ID: 34197225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.